Ithappenz Morning After Tablet
NDC Package 58602-892-57

11-digit billing NDC: 58602089257

Package Information

Ithappenz Morning After (levonorgestrel) tablets is take as soon as possible within 72 hours (3 days) after unprotected sex. This formulation utilizes a tablet delivery system. Marketed by Aurohealth Llc, this product is identified by NDC 58602-892 and is authorized under FDA application ANDA206867.

Identification & Billing

NDC Package Code
58602-892-57
Package Description
1 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
58602089257
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ithappenz Morning After
Non-Proprietary Name
Levonorgestrel
Substance Name
Levonorgestrel
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose.

Regulatory & Marketing

Labeler Name
Aurohealth Llc
Product Type
Human Otc Drug
FDA Application #
ANDA206867
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-14-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58602-892-57 identifies a specific commercial package of 1 blister pack in 1 carton / 1 tablet in 1 blister pack of Ithappenz Morning After, a human over the counter drug labeled by Aurohealth Llc. This tablet is formulated for oral use and contains levonorgestrel as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurohealth Llc on November 14, 2022. The current certification is valid through December 31, 2027.

How is this Aurohealth Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58602089257. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58602-892-57
11-Digit CMS (5-4-2)
58602-0892-57

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.